We are live on ! Find out more
ACM

AIGH Capital Management Portfolio holdings

AUM $1.59B
1-Year Est. Return 855.46%
This Fund
S&P 500
This Quarter Est. Return
+39%
1 Year Est. Return
+855.46%
3 Year Est. Return
+3,007.26%
5 Year Est. Return
+4,204.76%
10 Year Est. Return
–
AUM
$413M
AUM Growth
+$58.3M
Cap. Flow
-$3.22B
Cap. Flow %
-779.52%
Top 10 Hldgs %
67.54%
Holding
46
New
8
Increased
12
Reduced
10
Closed
12

Top Buys

Rank Stock Value
1
KYTX icon
Kyverna Therapeutics
KYTX
+$11.1M
2
VNDA icon
Vanda Pharmaceuticals
VNDA
+$11M
3
ABEO icon
Abeona Therapeutics
ABEO
+$10.1M
4
BKTI icon
BK Technologies
BKTI
+$8.06M
5
BYRN icon
Byrna Technologies
BYRN
+$7.69M

Top Sells

Rank Stock Value
1
MXL icon
MaxLinear
MXL
+$17.8M
2
LUMN icon
Lumen
LUMN
+$15.6M
3
ZVRA icon
Zevra Therapeutics
ZVRA
+$11.7M
4
APPS icon
Digital Turbine
APPS
+$9.75M
5
PSNL icon
Personalis
PSNL
+$8.68M

Sector Composition

Rank Sector Weight
1 Healthcare 44.17%
2 Technology 34.3%
3 Industrials 3.4%
4 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RNXT icon
26
RenovoRx
RNXT
$51M
$3.67M 0.89%
2,833,894
+218,701
+8% +$219K
GRCE
27
Grace Therapeutics
GRCE
$34.7M
$3.15M 0.76%
907,217
– –
ELUT icon
28
Elutia
ELUT
$38.3M
$2.13M 0.51%
3,068,185
-96,943
-3% -$73.6K
NRXS icon
29
Neuraxis
NRXS
$86.7M
$1.82M 0.44%
400,000
– –
IPWR icon
30
Ideal Power
IPWR
$76.5M
$1.52M 0.37%
491,989
-21,058
-4% -$92.8K
SMTK
31
SmartKem
SMTK
$4.06M
$719K 0.17%
675,000
+249,723
+59% +$446K
QNRX
32
Quoin Pharmaceuticals
QNRX
$9.64M
$712K 0.17%
+49,323
New +$671K
BFRI icon
33
Biofrontera
BFRI
$16.1M
$522K 0.13%
915,210
-130,840
-13% -$118K
APRE icon
34
Aprea Therapeutics
APRE
$8.14M
$316K 0.08%
370,541
-168,759
-31% -$207K
AMBA icon
35
Ambarella
AMBA
$3.86B
– –
-50,000
Closed -$4.13M
APPS icon
36
Digital Turbine
APPS
$1.71B
– –
-1,523,068
Closed -$9.75M
ELVA
37
Electrovaya
ELVA
$473M
– –
-192,100
Closed -$1.13M
GLW icon
38
CALL
Corning
GLW
$143B
– –
-3,829,453
Closed -$12.3M
LUMN icon
39
Lumen
LUMN
$6.51B
– –
-2,550,000
Closed -$15.6M
MBLY icon
40
CALL
Mobileye
MBLY
$2.19B
– –
-4,423,008
Closed -$11.3M
MXL icon
41
MaxLinear
MXL
$6.8B
– –
-1,107,504
Closed -$17.8M
PHAT icon
42
Phathom Pharmaceuticals
PHAT
$680M
– –
-429,000
Closed -$5.05M
VPG icon
43
Vishay Precision Group
VPG
$941M
– –
-250,000
Closed -$8.01M
VUZI icon
44
Vuzix
VUZI
$220M
– –
-898,648
Closed -$2.81M
ZVRA icon
45
Zevra Therapeutics
ZVRA
$676M
– –
-1,231,932
Closed -$11.7M
VELO
46
Velo3D Inc
VELO
$414M
– –
-1,719,874
Closed -$5.28M
1
2

Similar funds

VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

AIGH Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, AIGH Capital Management held 46 positions worth $413M, up 16% from $355M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

AIGH Capital Management withdrew a net $3.22B in Q4 2025, closing 12 positions and reducing 10 holdings. Its most notable exit was MaxLinear, an estimated $17.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 32% a quarter earlier, followed by Technology and Industrials.

Against the trend, AIGH Capital Management opened a new position in Kyverna Therapeutics worth $14.1M.

  • AIGH Capital Management's largest Q4 2025 buy was Kyverna Therapeutics: 1,500,000 shares worth $14.1M.
  • AIGH Capital Management added most to BK Technologies in Q4 2025, an estimated $8.06M increase.
  • AIGH Capital Management's biggest Q4 2025 reduction was Personalis, cutting an estimated $8.68M.
  • AIGH Capital Management fully exited MaxLinear in Q4 2025, selling an estimated $17.8M.
  • AIGH Capital Management's ten largest holdings make up 68% of its $413M portfolio in Q4 2025.
  • AIGH Capital Management opened 8 new positions and closed 12 in Q4 2025.
  • AIGH Capital Management's portfolio value rose 16% quarter-over-quarter to $413M.

Based on AIGH Capital Management's 13F filing for Q4 2025, filed 2 Feb 2026.